Literature DB >> 20192928

Methicillin-resistant Staphylococcus aureus (MRSA) as a cause of nosocomial wound infections.

Maida Sisirak1, Amra Zvizdic, Mirsada Hukic.   

Abstract

Postoperative wound infections represent about 16% of hospital-acquired infections. Staphylococcus aureus is the most common cause of nosocomial wound infections. Increased frequency of Methicillin-resistant Staphylococcus aureus (MRSA) in hospitalized patients and possibility of vancomycin resistance requires permanent control of MRSA spread in the hospital.The purpose of this study was to analyse the frequency of Methicillin-resistant Staphylococcus aureus (MRSA) in the swabs taken from the surgical wounds, the presence of MRSA infection in surgical departments and to examine antimicrobial susceptibility of MRSA isolates. Wound swabs were examined from January 2006 to December 2008. The isolates were identified by conventional methods. Antimicrobial susceptibility testing was performed by Kirby-Bauer disc-diffusion method as per NCCLS guidelines.A total of 5755 wound swabs were examined: 938 (16,3%) swabs were sterile and 4817 (83,7%) were positive. Staphylococcus aureus was isolated in 1050 (22,0%) swabs and it was the most common cause of wound infections. MRSA was isolated from 12,4% samples in 2006, from 6,7% samples in 2007 and from 3,7% samples during 2008. Wound infections caused by MRSA dominated in the department of plastic surgery (24,4%) and in the department of orthopaedic surgery (24,1%). Antimicrobial susceptibility testing showed that 73% of MRSA isolates were with the same antibiotic sensitivity pattern (antibiotyp)-sensitive only to vancomycin, tetracycline, fucid acid and trimethoprim/sulfamethoxasole. Our results show decreasing of MRSA infection in the surgical wards. These results appear to be maintained with strategies for preventing nosocomial infection: permanent education, strong application of protocols and urging the implementation of strict infection control policy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20192928      PMCID: PMC5596608          DOI: 10.17305/bjbms.2010.2733

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  17 in total

1.  Suitability of the NNIS index for estimating surgical-site infection risk at a small university hospital in Brazil.

Authors:  M L Campos; Z M Cipriano; P F Freitas
Journal:  Infect Control Hosp Epidemiol       Date:  2001-05       Impact factor: 3.254

Review 2.  Recognition, prevention, surveillance, and management of surgical site infections: introduction to the problem and symposium overview.

Authors:  W J Martone; R L Nichols
Journal:  Clin Infect Dis       Date:  2001-09-01       Impact factor: 9.079

3.  National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.

Authors: 
Journal:  Am J Infect Control       Date:  2004-12       Impact factor: 2.918

Review 4.  Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.

Authors:  Curtis G Gemmell; David I Edwards; Adam P Fraise; F Kate Gould; Geoff L Ridgway; Rod E Warren
Journal:  J Antimicrob Chemother       Date:  2006-02-28       Impact factor: 5.790

Review 5.  Epidemiology of the genetic elements responsible for acquired glycopeptide resistance in enterococci.

Authors:  N Woodford
Journal:  Microb Drug Resist       Date:  2001       Impact factor: 3.431

6.  Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.

Authors:  K Hiramatsu; N Aritaka; H Hanaki; S Kawasaki; Y Hosoda; S Hori; Y Fukuchi; I Kobayashi
Journal:  Lancet       Date:  1997-12-06       Impact factor: 79.321

7.  A five-year prospective study of 23,649 surgical wounds.

Authors:  P J Cruse; R Foord
Journal:  Arch Surg       Date:  1973-08

8.  Vancomycin-resistant enterococci.

Authors:  A H Uttley; C H Collins; J Naidoo; R C George
Journal:  Lancet       Date:  1988 Jan 2-9       Impact factor: 79.321

9.  Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides.

Authors:  F C Tenover; M V Lancaster; B C Hill; C D Steward; S A Stocker; G A Hancock; C M O'Hara; S K McAllister; N C Clark; K Hiramatsu
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

Review 10.  Vancomycin resistance in staphylococci.

Authors:  Arjun Srinivasan; James D Dick; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

View more
  15 in total

1.  Molecular characterisation of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in inpatients and outpatients in Bosnia and Herzegovina.

Authors:  Selma Uzunović-Kamberović; Michelle I A Rijnders; Ellen E Stobberingh; Amir Ibrahimagić; Farah Kamberović; Tatjana Ille
Journal:  Wien Med Wochenschr       Date:  2012-10-10

2.  Carmellose Mucoadhesive Oral Films Containing Vermiculite/Chlorhexidine Nanocomposites as Innovative Biomaterials for Treatment of Oral Infections.

Authors:  Jan Gajdziok; Sylva Holešová; Jan Štembírek; Erich Pazdziora; Hana Landová; Petr Doležel; David Vetchý
Journal:  Biomed Res Int       Date:  2015-04-30       Impact factor: 3.411

3.  Phytochemical prospection and modulation of antibiotic activity in vitro by Lippia origanoides H.B.K. in methicillin resistant Staphylococcus aureus.

Authors:  Humberto Medeiros Barreto; Filipe Cerqueira Fontinele; Aldeídia Pereira de Oliveira; Daniel Dias Rufino Arcanjo; Bernadete Helena Cavalcanti Dos Santos; Aislan Pereira Lira de Abreu; Henrique Douglas Melo Coutinho; Romezio Alves Carvalho da Silva; Taciana Oliveira de Sousa; Maria das Graças Freire de Medeiros; Antonia Maria das Graças Lopes Citó; José Arimateia Dantas Lopes
Journal:  Biomed Res Int       Date:  2014-02-10       Impact factor: 3.411

4.  Prevalence and factors associated with wound colonization by Staphylococcus spp. and Staphylococcus aureus in hospitalized patients in inland northeastern Brazil: a cross-sectional study.

Authors:  Gilmara Celli Maia Almeida; Marquiony Marques dos Santos; Nara Grazieli Martins Lima; Thiago André Cidral; Maria Celeste Nunes Melo; Kenio Costa Lima
Journal:  BMC Infect Dis       Date:  2014-06-13       Impact factor: 3.090

5.  Genomic and transcriptomic differences in community acquired methicillin resistant Staphylococcus aureus USA300 and USA400 strains.

Authors:  Marcus B Jones; Christopher P Montgomery; Susan Boyle-Vavra; Kenneth Shatzkes; Rosslyn Maybank; Bryan C Frank; Scott N Peterson; Robert S Daum
Journal:  BMC Genomics       Date:  2014-12-19       Impact factor: 3.969

6.  Antimicrobial Peptides: A Potential Therapeutic Option for Surgical Site Infections.

Authors:  Berthony Deslouches; Y Peter Di
Journal:  Clin Surg       Date:  2017-11-16

7.  Antimicrobial Activity of Electrospun Polyvinyl Alcohol Nanofibers Filled with Poly[2-(tert-butylaminoethyl) Methacrylate]-Grafted Graphene Oxide Nanosheets.

Authors:  Chien-Lin Huang; Kun-Mu Lee; Zheng-Xian Liu; Ruo-Yu Lai; Chih-Kuang Chen; Wen-Cheng Chen; Jen-Fu Hsu
Journal:  Polymers (Basel)       Date:  2020-06-28       Impact factor: 4.329

Review 8.  Targeting the Bacterial Protective Armour; Challenges and Novel Strategies in the Treatment of Microbial Biofilm.

Authors:  Nor Fadhilah Kamaruzzaman; Li Peng Tan; Khairun Anisa Mat Yazid; Shamsaldeen Ibrahim Saeed; Ruhil Hayati Hamdan; Siew Shean Choong; Weng Kin Wong; Alexandru Chivu; Amanda Jane Gibson
Journal:  Materials (Basel)       Date:  2018-09-13       Impact factor: 3.623

9.  THE FREQUENCY OF COMMUNITY-ACQUIRED METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (CA-MRSA) AMONG SAMPLES IN INSTITUTE FOR PUBLIC HEALTH IN CANTON SARAJEVO.

Authors:  Sabaheta Bektas; Amina Obradovic; Mufida Aljicevic; Fatima Numanovic; Dunja Hodzic; Lutvo Sporisevic
Journal:  Mater Sociomed       Date:  2016-01-30

10.  Antibacterial activity and therapeutic efficacy of Fl-P(R)P(R)P(L)-5, a cationic amphiphilic polyproline helix, in a mouse model of staphylococcal skin infection.

Authors:  Shankar Thangamani; Manish Nepal; Jean Chmielewski; Mohamed N Seleem
Journal:  Drug Des Devel Ther       Date:  2015-10-22       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.